The new heterocyclic compound 4-methyl-3-((4-(pyridin-3-yl) pyrimidin-2-yl) amino) benzoic acid (1) designed utilizing methyl 3-amino-4-methylbenzoate (2) as a starting material was successfully fabricated and eventually characterized utilizing single crystal X-ray crystallography, 1H NMR and IR. In biological study, to evaluate the protective effect of compound on acute tracheobronchitis ICR mice model, the ELISA assay was performed to determine the level of inflammatory mediators IL-6 and TNF-α in serum. Then, the western blot was performed to determine the activation of PKA-NF-κB pathway in tissues.
KajikawaS., NodaK., NozakiY., Necrotizing tracheobronchitis associated with rheumatoid arthritis, Respir Med Case Rep20 (2016), 31–33.
2.
YeungV., GovindA.G., ArastuS., HenryC.H., Tracheobronchitis in a Patient With Crohn’s Disease, ACG Case Rep J3 (2016), 181–183.
3.
YangN., LiC., TianG., ZhuM., BuW., ChenJ., HouX., DiL., JiaX., DongZ., FengL., Organic acid component from Taraxacum mongolicum Hand-Mazz alleviates inflammatory injury in lipopolysaccharide-induced acute tracheobronchitis of ICR mice through TLR4/NF-κB signaling pathway, Int Immunopharmacol34 (2016), 92–100.
4.
NishiyamaK.H., Falcão EdeA.,
KayF.U.,
TelesG.B.,
Bernardi FdelC. and
FunariM.B., Acute tracheobronchitis caused by Aspergillus: case report and imaging findings, Radiol Bras47 (2014), 317–319.
5.
CravenD.E., HudcovaJ., CravenK.A., ScopaC., LeiY., Antibiotic treatment of ventilator-associated tracheobronchitis: to treat or not to treat, Curr Opin Crit Care20 (2014), 532–541.
6.
BansalA., JaroudiS., GavinM., PeirisA.N., Treatment-Free Remission After Second-Line Nilotinib Treatment, Ann Intern Med169 (2018), 509–510.
7.
IriyamaN., SugimotoK.J., SatoE., TakakuT., TokuhiraM., NakazatoT., IshikawaM., FujitaH., FujiokaI., KimuraY., AsouN., KizakiM., KomatsuN., HattaY., KawaguchiT., Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis, Med Oncol35 (2018), 142.
8.
TianX., ZhangH., HeimbachT., HeH., BuchbinderA., AghoghovbiaM., Hourcade-PotelleretF., Clinical Pharmacokinetic and Pharmacodynamic Overview of Nilotinib, a Selective Tyrosine Kinase Inhibitor, J Clin Pharmacol58 (2018), 1533–1540.
9.
SheldrickG.M. (1997). SHELXL-97, Program for Solution Crystal Structure and Refinement, University of Göttingen,
Germany.
10.
ParkS., ChoiJ.J., ParkB.K., YoonS.J., ChoiJ.E., JinM., Pheophytin a and chlorophyll a suppress neuroinflammatory responses in lipopolysaccharide and interferon-ν-stimulated BV2 microglia, Life Sci103 (2014), 59–67.
11.
YangN., LiC., TianG., ZhuM., BuW., ChenJ., HouX., DiL., JiaX., DongZ., FengL., Organic acid component from Taraxacum mongolicum Hand-Mazz alleviates inflammatory injury in lipopolysaccharide-induced acute tracheobronchitis of ICR mice through TLR4/NF-κB signaling pathway, Int Immunopharmacol34 (2016), 92–100.
